Mostrar el registro sencillo del ítem
dc.contributor.author
Di Lello, Federico Alejandro
dc.contributor.author
Culasso, Andrés Carlos Alberto
dc.contributor.author
Campos, Rodolfo Hector
dc.date.available
2017-05-09T19:44:09Z
dc.date.issued
2015-07
dc.identifier.citation
Di Lello, Federico Alejandro; Culasso, Andrés Carlos Alberto; Campos, Rodolfo Hector; Inter and intrapatient evolution of hepatitis C virus; Mexican Assoc Hepatology; Annals Of Hepatology; 14; 4; 7-2015; 442-449
dc.identifier.issn
1665-2681
dc.identifier.uri
http://hdl.handle.net/11336/16170
dc.description.abstract
Hepatitis C virus (HCV) has a short replication time, high mutation rates and large population sizes, all of which make it an excellent experimental model for evolution studies, because evolution can be visualized in real-time. In this review, we discuss the implications to study HCV evolution at the interpatient and intrapatient levels of infection. The HCV interpatient dynamics is relatively slow, because the generation time is generally long. Then, at population level, the HCV diversity originated by the high mutation and replication rates is modulated by the bottleneck at transmission. Thus, when the virus is transmitted to other hosts, viral diversity is reduced as a result of the founder effect. On the other hand, during intrapatient infection, HCV evolves rapidly, resulting in quasispecies. Accumulated evidence suggests that this quasispecies composition of the HCV population within the same individual may allow the virus to evade the immune response or escape treatment, leading to chronic infection. Thus, a better understanding of the complexities underlying the molecular evolution of HCV in natural populations is needed before accurate predictions of viral evolution can be made. In summary, HCV evolves both within and among patients. Consequently, HCV evolution should be studied at both levels in order to better understand the natural history of the virus and its potential implications in epidemiology, outcome of infection and progression of liver disease.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Mexican Assoc Hepatology
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Hcv
dc.subject
Quasispecies
dc.subject
Liver Disease
dc.subject.classification
Otras Medicina Básica
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Inter and intrapatient evolution of hepatitis C virus
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2017-04-28T17:10:19Z
dc.journal.volume
14
dc.journal.number
4
dc.journal.pagination
442-449
dc.journal.pais
México
dc.description.fil
Fil: Di Lello, Federico Alejandro. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Culasso, Andrés Carlos Alberto. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Campos, Rodolfo Hector. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Virología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.journal.title
Annals Of Hepatology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.annalsofhepatology.com/vista?accion=viewArticle&idart=1197
Archivos asociados